Projects per year
Fingerprint
Dive into the research topics where Ann-Kathrin Eisfeld is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 1 Similar Profiles
Collaborations and top research areas from the last five years
Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
Projects
- 3 Active
-
Towards an inclusive genomic risk classification for acute myeloid leukemia (AML)
Eisfeld, A.-K. (PI), Mardis, E. (CoPI) & Grimes, H. H. L. (CoPI)
09/18/23 → 07/31/25
Project: Research
-
The role of inflammation in the regulation of immune response in acute myeloid leukemia
Aifantis, I. (PI) & Eisfeld, A.-K. (CoPI)
07/6/23 → 06/30/25
Project: Research
-
Understanding Treatment Response Patterns And Therapy Resistance In IDH-Mutant AML
Eisfeld, A.-K. (PI), Mims, A. (CoPI) & Mardis, E. (CoPI)
07/1/22 → 06/30/25
Project: Research
-
Prognostic, biological, and structural implications of FLT3-JMD point mutations in acute myeloid leukemia: an analysis of Alliance studies
Anabtawi, N., Nicolet, D., Alotaibi, N., Buelow, D. R., Orwick, S., Gregory, T., Raj, R., Coleman, K., Kolitz, J. E., Powell, B. L., Blum, W. G., Baer, M. R., Byrd, J. C., Stock, W., Uy, G. L., Mrózek, K., Eisfeld, A. K., Cheng, X., Baker, S. & Blachly, J. S., 2025, (Accepted/In press) In: Leukemia. 612880.Research output: Contribution to journal › Article › peer-review
Open Access -
Acute Myeloid Leukemia Genomics: Impact on Care and Remaining Challenges
Eisfeld, A. K. & Mardis, E. R., Jan 1 2024, In: Clinical Chemistry. 70, 1, p. 4-12 9 p.Research output: Contribution to journal › Comment/debate
1 Scopus citations -
Disparities in acute myeloid leukemia treatments and outcomes
Eisfeld, A. K., Mar 1 2024, In: Current Opinion in Hematology. 31, 2, p. 58-63 6 p.Research output: Contribution to journal › Review article › peer-review
4 Scopus citations -
Identifying long-term survivors and those at higher or lower risk of relapse among patients with cytogenetically normal acute myeloid leukemia using a high-dimensional mixture cure model
Archer, K. J., Fu, H., Mrózek, K., Nicolet, D., Mims, A. S., Uy, G. L., Stock, W., Byrd, J. C., Hiddemann, W., Braess, J., Spiekermann, K., Metzeler, K. H., Herold, T. & Eisfeld, A. K., Dec 2024, In: Journal of Hematology and Oncology. 17, 1, 28.Research output: Contribution to journal › Letter › peer-review
Open Access -
Improving risk stratification for 2022 European LeukemiaNet favorable-risk patients with acute myeloid leukemia
Archer, K. J., Fu, H., Mrózek, K., Nicolet, D., Mims, A. S., Uy, G. L., Stock, W., Byrd, J. C., Hiddemann, W., Metzeler, K. H., Rausch, C., Krug, U., Sauerland, C., Görlich, D., Berdel, W. E., Woermann, B. J., Braess, J., Spiekermann, K., Herold, T. & Eisfeld, A. K., Nov 4 2024, In: Innovation. 5, 6, 100719.Research output: Contribution to journal › Article › peer-review
Open Access